Here are the latest quarterly results of the stocks in the . For more detailed updates, check the latest stock quotes.
Click on title to sort | Sep 2019 | Sep 2020 | YoY %-Change | Get More Info | ||||
---|---|---|---|---|---|---|---|---|
Name | Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (%) |
PAT (%) |
P/E* (x) |
|
AUROBINDO PHARMA | 56,005 | 6,395 | 64,834 | 8,278 | 15.8% | 29.4% | 15.3 | More Info
|
AUROBINDO PHARMA | 56,005 | 6,395 | 64,834 | 8,278 | 15.8% | 29.4% | 15.3 | More Info
|
AUROBINDO PHARMA | 56,005 | 6,395 | 64,834 | 8,278 | 15.8% | 29.4% | 15.3 | More Info
|
AUROBINDO PHARMA | 56,005 | 6,395 | 64,834 | 8,278 | 15.8% | 29.4% | 15.3 | More Info
|
BIOCON | 15,673 | 2,632 | 17,448 | 2,004 | 11.3% | -23.9% | 29.4 | More Info
|
BIOCON | 15,673 | 2,632 | 17,448 | 2,004 | 11.3% | -23.9% | 29.4 | More Info
|
CIPLA | 43,958 | 4,804 | 50,383 | 6,619 | 14.6% | 37.8% | 15.2 | More Info
|
CIPLA | 43,958 | 4,804 | 50,383 | 6,619 | 14.6% | 37.8% | 15.2 | More Info
|
CIPLA | 43,958 | 4,804 | 50,383 | 6,619 | 14.6% | 37.8% | 15.2 | More Info
|
DIVIS LABORATORIES | 14,456 | 3,568 | 17,493 | 5,196 | 21.0% | 45.6% | 53.8 | More Info
|
DIVIS LABORATORIES | 14,456 | 3,568 | 17,493 | 5,196 | 21.0% | 45.6% | 53.8 | More Info
|
GLENMARK PHARMA | 28,150 | 2,555 | 29,525 | 2,340 | 4.9% | -8.4% | N.A. | More Info
|
LUPIN | 38,822 | -1,826 | 38,350 | 2,131 | -1.2% | N.A. | 18.4 | More Info
|
LUPIN | 38,822 | -1,826 | 38,350 | 2,131 | -1.2% | N.A. | 18.4 | More Info
|
LUPIN | 38,822 | -1,826 | 38,350 | 2,131 | -1.2% | N.A. | 18.4 | More Info
|
PIRAMAL ENTERPRISES | 36,036 | 4,580 | 33,018 | 5,781 | -8.4% | 26.2% | N.A. | More Info
|
SUN PHARMA | 81,234 | 11,674 | 85,531 | 19,484 | 5.3% | 66.9% | 13.0 | More Info
|
SUN PHARMA | 81,234 | 11,674 | 85,531 | 19,484 | 5.3% | 66.9% | 13.0 | More Info
|
ZYDUS LIFESCIENCES | 33,666 | 829 | 36,589 | 3,895 | 8.7% | 369.8% | 11.4 | More Info
|
ZYDUS LIFESCIENCES | 33,666 | 829 | 36,589 | 3,895 | 8.7% | 369.8% | 11.4 | More Info
|
Sector Aggregate | 826,601 | 79,053 | 902,202 | 128,637 | 9.1% | 62.7% | ||
* Trailing 12 months earnings, excluding extraordinary / exceptional items. |
Jun 2020 Results | Dec 2020 Results | Latest Quarter Results | View All Results |